Neurostimulation Devices Market Size

  • Report ID: 4239
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Neurostimulation Devices Market Size

Neurostimulation Devices Market size was valued at USD 11.32 billion in 2024 and is poised to exceed USD 50.56 billion by the end of 2037, registering over 12.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of neurostimulation devices is evaluated at USD 12.42 billion.

The market is estimated to grow on the back of increasing neurological surgeries and disorders. According to estimates, about 22 million people suffer from neurological disorders every year, of which 13 million require surgery.  Moreover, an increasing number of minimally invasive surgeries across the globe is also anticipated to fuel the growth of the market in the coming years. Additionally, increasing the adoption of neurostimulation devices for the treatment of neurological disorders and increasing patient awareness are also expected to boost the growth of the global market during the forecast period.

The global neurostimulation devices market is also estimated to witness growth on account of the increasing level of the geriatric population globally. According to the World Health Organization (WHO) data, the population aged 60 years and above stood at around 1 billion in 2020, which is projected to reach 1.4 billion by the end of 2030.  According to the World Health Organization (WHO) data, the population of people aged 60 years and above in China was around 254 million in 2019, with about 176 million people aged 65 and above. By 2040, it is estimated that there will be about 402 million people over the age of 60 in China. Moreover, the increasing technological advancement and innovation in these neurostimulation devices are anticipated to drive market growth during the forecast period.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4239
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of neurostimulation devices is evaluated at USD 12.42 billion.

The neurostimulation devices market size was valued at USD 11.32 billion in 2024 and is poised to exceed USD 50.56 billion by the end of 2037, registering over 12.1% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of chronic pain and increasing neurological disorders will drive the market growth.

North America industry is expected to account for majority revenue share by 2037, driven by increasing prevalence of neurological disorders and the increasing level of the geriatric population in the region.

The major players in the market include Abbott Laboratories, Boston Scientific Corporation, Integer Holdings Corporation, Medtronic, Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Synapse Biomedical Inc., Soterix Medical, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample